FibroBiologics, Inc. Common Stock (FBLG) — Tangible Net Worth Ratio
FibroBiologics, Inc. Common Stock (FBLG) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($125.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. For live market cap and overall valuation, see FBLG market cap overview.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
FibroBiologics, Inc. Common Stock Tangible Net Worth Ratio (2024–2025)
This chart shows how FibroBiologics, Inc. Common Stock's Tangible Net Worth Ratio has changed across 2 annual periods from 2024 to 2025. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $125.00K with intangible assets of $0.00 USD. Also explore FBLG net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for FibroBiologics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for FibroBiologics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See FBLG free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $2.73 Million | $0.00 | $16.45 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $1.25 Million | $0.00 | $11.82 Million | — |